Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Glioblastoma Multiforme (GBM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00004024
What this trial is testing

Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma

Who this might be right for
Brain and Central Nervous System Tumors
Barbara Ann Karmanos Cancer Institute 60
Testing effectiveness (Phase 2)Looking for participantsNCT07501559
What this trial is testing

A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in Patients With Recurrent Glioblastoma (rGBM)

Who this might be right for
Recurrent Glioblastoma Multiforme(GBM)
Jecho Biopharmaceuticals Co., Ltd. 40
Early research (Phase 1)Study completedNCT00354068
What this trial is testing

Imatinib Mesylate and Temozolomide in Treating Patients With Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Duke University 65
Very early researchUnknownNCT04315584
What this trial is testing

FDG and FDOPA PET Demonstration of Functional Brain Abnormalities

Who this might be right for
Glioblastoma
University of Virginia 5
Very early researchStudy completedNCT03360708
What this trial is testing

Vaccine Therapy in Treating Patients With Recurrent Glioblastoma

Who this might be right for
Giant Cell GlioblastomaRecurrent GlioblastomaRecurrent Gliosarcoma
Mayo Clinic 20
Testing effectiveness (Phase 2)UnknownNCT04888611
What this trial is testing

Neoadjuvant PD-1 Antibody Alone or Combined With DC Vaccines for Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
Huashan Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT01966809
What this trial is testing

Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas

Who this might be right for
Brain Tumor, Recurrent
Harry T Whelan, MD 1
Large-scale testing (Phase 3)UnknownNCT01308632
What this trial is testing

Metronomic Temozolamide in Patients With Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Grupo Español de Investigación en Neurooncología 30
Testing effectiveness (Phase 2)Study completedNCT00362921
What this trial is testing

Gliadel Wafer and O6-Benzylguanine in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Recurrent Adult Brain Tumor
Duke University 52
Early research (Phase 1)Active Not RecruitingNCT03389230
What this trial is testing

Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma

Who this might be right for
GlioblastomaMalignant GliomaRecurrent Glioma+2 more
City of Hope Medical Center 29
Testing effectiveness (Phase 2)Study completedNCT04492163
What this trial is testing

Open-Label Pilot Study of OPTUNE® With High Density Transducer Arrays for the Treatment of Recurrent GBM

Who this might be right for
Glioblastoma Multiforme
NovoCure GmbH 25
Testing effectiveness (Phase 2)Study completedNCT00099060
What this trial is testing

Lapatinib in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT01478178
What this trial is testing

Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma

Who this might be right for
GliomaGlioblastomaGlioblastoma Multiforme+2 more
Kintara Therapeutics, Inc. 55
Not applicableLooking for participantsNCT06273176
What this trial is testing

The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma

Who this might be right for
Glioblastoma, IDH-wildtypeGlioblastomaGlioblastoma Multiforme of Brain+6 more
Erasmus Medical Center 225
Testing effectiveness (Phase 2)Ended earlyNCT00003535
What this trial is testing

Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma

Who this might be right for
High Grade Glioma
Burzynski Research Institute 9
Early research (Phase 1)Looking for participantsNCT05577091
What this trial is testing

Tris-CAR-T Cell Therapy for Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
Beijing Tiantan Hospital 10
Testing effectiveness (Phase 2)Ended earlyNCT01189240
What this trial is testing

RO4929097and Bevacizumab in Treating Patients With Progressive or Recurrent Malignant Glioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+3 more
National Cancer Institute (NCI) 13
Early research (Phase 1)Study completedNCT00074243
What this trial is testing

CC-8490 in Treating Patients With Recurrent or Refractory High-Grade Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT02049489
What this trial is testing

ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma

Who this might be right for
Glioblastoma Multiforme
Precision Life Sciences Group 20
Testing effectiveness (Phase 2)Study completedNCT00800917
What this trial is testing

Temsirolimus and Bevacizumab in Recurrent Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Rigshospitalet, Denmark 12
Next Page